Literature DB >> 24405616

A comparison of surgical approaches for primary hip arthroplasty: a cohort study of patient reported outcome measures (PROMs) and early revision using linked national databases.

Simon S Jameson1, James Mason2, Paul Baker1, Paul J Gregg3, Ian A McMurtry4, David J Deehan5, Mike R Reed6.   

Abstract

The posterior and lateral approaches to primary hip arthroplasty were compared using national data from England and Wales. Specific component combinations of the most commonly used cemented and cementless implant brands were analysed separately. There was no significant difference between the approaches for all-cause revision risk (cemented: P = 0.726, cementless: P = 0.295) and revision for dislocation (P = 0.176, P = 0.695) at 12 months following 37,593 procedures, after adjusting for patient and surgical variables. Analysis of 3881 linked episodes found the posterior approach was associated with significantly higher improvement in function (Oxford Hip Score: 20.8 versus 18.9, P < 0.001 (cemented procedures); 21.7 versus 20.2, P = 0.008 (cementless), EQ5D index: 0.416 versus 0.383, P = 0.003; 0.431 versus 0.384, P = 0.003). The posterior approach may offer a functional benefit (albeit small clinically), without increased revision risk.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  joint registry data; lateral approach; outcome scores; posterior approach; primary hip replacement

Mesh:

Year:  2013        PMID: 24405616     DOI: 10.1016/j.arth.2013.11.027

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  7 in total

1.  A comparison of the omega and posterior approaches on patient reported function and radiological outcomes following total hip replacement.

Authors:  James R Berstock; Ashley W Blom; Michael R Whitehouse
Journal:  J Orthop       Date:  2017-06-24

2.  Histological and ultrastructural degenerative findings in the gluteus medius tendon after hip arthroplasty.

Authors:  Mustafa Ibrahim; Urban Hedlundh; Ninni Sernert; Khaled Meknas; Lars Haag; Tomas Movin; Nikos Papadogiannakis; Jüri-Toomas Kartus
Journal:  J Orthop Surg Res       Date:  2021-05-26       Impact factor: 2.359

3.  Comparison of outcome measures and complication rates following three different approaches for primary total hip arthroplasty: a pragmatic randomised controlled trial.

Authors:  Adrian J Talia; Cassandra Coetzee; Oren Tirosh; Phong Tran
Journal:  Trials       Date:  2018-01-08       Impact factor: 2.279

4.  Patient-reported outcome after total hip arthroplasty: comparison between lateral and posterior approach.

Authors:  Signe Rosenlund; Leif Broeng; Anders Holsgaard-Larsen; Carsten Jensen; Søren Overgaard
Journal:  Acta Orthop       Date:  2017-02-18       Impact factor: 3.717

5.  No Threshold Exists for Recommending Revision Surgery in Metal-on-Metal Hip Arthroplasty Patients With Adverse Reactions to Metal Debris: A Retrospective Cohort Study of 346 Revisions.

Authors:  Gulraj S Matharu; Fiona Berryman; David J Dunlop; Matthew P Revell; Andrew Judge; David W Murray; Hemant G Pandit
Journal:  J Arthroplasty       Date:  2019-03-13       Impact factor: 4.757

6.  The impact of a digital joint school educational programme on post-operative outcomes following lower limb arthroplasty: a retrospective comparative cohort study.

Authors:  Joanne Gray; Stephen McCarthy; Esther Carr; Gerard Danjoux; Rhiannon Hackett; Andrew McCarthy; Peter McMeekin; Natalie Clark; Paul Baker
Journal:  BMC Health Serv Res       Date:  2022-04-29       Impact factor: 2.908

7.  Patient-reported outcome measures in arthroplasty registries Report of the Patient-Reported Outcome Measures Working Group of the International Society of Arthroplasty Registries Part II. Recommendations for selection, administration, and analysis.

Authors:  Ola Rolfson; Eric Bohm; Patricia Franklin; Stephen Lyman; Geke Denissen; Jill Dawson; Jennifer Dunn; Kate Eresian Chenok; Michael Dunbar; Søren Overgaard; Göran Garellick; Anne Lübbeke
Journal:  Acta Orthop       Date:  2016-05-26       Impact factor: 3.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.